Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Head and Neck Cancer

  Free Subscription


Articles published in Gastrointest Endosc

Retrieve available abstracts of 171 articles:
HTML format



Single Articles


    September 2021
  1. FREI NF, Bergman JJGHM, Pouw RE
    Screening for Barrett's esophagus: Ready for prime time or still hard to swallow?
    Gastrointest Endosc. 2021;94:506-508.
    PubMed    


  2. IYER PG, Taylor WR, Slettedahl SW, Lansing RL, et al
    Validation of a methylated DNA marker panel for the nonendoscopic detection of Barrett's esophagus in a multisite case-control study.
    Gastrointest Endosc. 2021;94:498-505.
    PubMed     Abstract available


    August 2021
  3. MONTGOMERY EA, Haidry R
    Treating esophageal squamous cell carcinoma with ablation: the fear of what lies beneath.
    Gastrointest Endosc. 2021 Aug 18. pii: S0016-5107(21)01495.
    PubMed    


  4. XIA R, Li H, Shi J, Liu W, et al
    Cost-effectiveness of risk-stratified endoscopic screening for esophageal cancer in high-risk areas of China: a modeling study.
    Gastrointest Endosc. 2021 Aug 18. pii: S0016-5107(21)01563.
    PubMed     Abstract available


  5. KAMBOJ AK, Leggett CL
    Barrett's esophagus indefinite for dysplasia carries a definite risk of neoplasia.
    Gastrointest Endosc. 2021;94:271-272.
    PubMed    


  6. DUPREE A, Ehlken H, Rosch T, Luken M, et al
    Laparoscopic lymph node sampling: a new concept for patients with high-risk early esophagogastric junction cancer resected endoscopically.
    Gastrointest Endosc. 2021;94:282-290.
    PubMed     Abstract available


  7. EVERSON MA, Garcia-Peraza-Herrera L, Wang HP, Lee CT, et al
    A clinically interpretable convolutional neural network for the real-time prediction of early squamous cell cancer of the esophagus: comparing diagnostic performance with a panel of expert European and Asian endoscopists.
    Gastrointest Endosc. 2021;94:273-281.
    PubMed     Abstract available


  8. PHILLIPS R, Januszewicz W, Pilonis ND, O'Donovan M, et al
    The risk of neoplasia in patients with Barrett's esophagus indefinite for dysplasia: a multicenter cohort study.
    Gastrointest Endosc. 2021;94:263-270.
    PubMed     Abstract available


    July 2021
  9. YANG LS, Holt BA, Williams R, Norris R, et al
    Endoscopic features of buried Barrett's mucosa.
    Gastrointest Endosc. 2021;94:14-21.
    PubMed     Abstract available


    June 2021
  10. BARTEL MJ, Mousa OY, Brahmbhatt B, Coffman DL, et al
    Impact of topical budesonide on prevention of esophageal stricture after mucosal resection.
    Gastrointest Endosc. 2021;93:1276-1282.
    PubMed     Abstract available


  11. SOLFISBURG QS, Sami SS, Gabre J, Soroush A, et al
    Clinical significance of recurrent gastroesophageal junction intestinal metaplasia after endoscopic eradication of Barrett's esophagus.
    Gastrointest Endosc. 2021;93:1250-1257.
    PubMed     Abstract available


  12. ZHANG M, Zhu C, Wang Y, Kong Z, et al
    Differential diagnosis for esophageal protruded lesions using a deep convolution neural network in endoscopic images.
    Gastrointest Endosc. 2021;93:1261-1272.
    PubMed     Abstract available


    May 2021
  13. MWACHIRO MM, Dawsey SM
    Larger esophageal Lugol's unstained lesions need more follow-up: size as an important predictor for risk of premalignant lesions.
    Gastrointest Endosc. 2021;93:1074-1076.
    PubMed    


  14. DE GROOF J, Antonelli G, Dinis-Ribeiro MJ, Bergman JJ, et al
    Meta-analyses of machine learning in endoscopy: stacking apples and oranges.
    Gastrointest Endosc. 2021;93:1016-1018.
    PubMed    


  15. LIU M, Zhou R, Guo C, Xu R, et al
    Size of Lugol-unstained lesions as a predictor for risk of progression in premalignant lesions of the esophagus.
    Gastrointest Endosc. 2021;93:1065-1073.
    PubMed     Abstract available


    April 2021
  16. BABA ER, Uedo N, Rodrigues AL, da Costa Martins B, et al
    "KERATIN PEARLS IN MAGNIFYING ENDOSCOPY OF SUPERFICIAL ESOPHAGEAL SQUAMOUS CELL CARCINOMA".
    Gastrointest Endosc. 2021 Apr 22. pii: S0016-5107(21)01313.
    PubMed    


  17. HAIDRY R
    Endoluminal resective therapy for residual esophageal neoplasia after definitive chemoradiotherapy: Who are we helping-the patient or the endoscopist?
    Gastrointest Endosc. 2021;93:899-901.
    PubMed    


  18. SWEI E, Wagh MS
    Endoscopic submucosal dissection in the pharynx: Let's start at the very beginning!
    Gastrointest Endosc. 2021;93:828-830.
    PubMed    


  19. SAPP AR, Wander P, Ali U, Gong Y, et al
    The tongue: an unusual site for esophageal adenocarcinoma metastasis diagnosed with EUS-guided FNA.
    Gastrointest Endosc. 2021;93:977-978.
    PubMed    


  20. KAHN A, Priyan H, Dierkhising RA, Johnson ML, et al
    Outcomes of radiofrequency ablation by manual versus self-sizing circumferential balloon catheters for the treatment of dysplastic Barrett's esophagus: a multicenter comparative cohort study.
    Gastrointest Endosc. 2021;93:880-887.
    PubMed     Abstract available


  21. STRUYVENBERG MR, de Groof AJ, Fonolla R, van der Sommen F, et al
    Prospective development and validation of a volumetric laser endomicroscopy computer algorithm for detection of Barrett's neoplasia.
    Gastrointest Endosc. 2021;93:871-879.
    PubMed     Abstract available


  22. HANADA Y, Wang KK
    Safety and feasibility of same-day discharge after esophageal endoscopic submucosal dissection.
    Gastrointest Endosc. 2021;93:853-860.
    PubMed     Abstract available


  23. IIZUKA T, Kikuchi D, Suzuki Y, Tanaka M, et al
    Clinical relevance of endoscopic treatment for superficial pharyngeal cancer: feasibility of techniques corresponding to each location and long-term outcomes.
    Gastrointest Endosc. 2021;93:818-827.
    PubMed     Abstract available


    March 2021
  24. KAUL V, Diehl D, Enslin S, Infantolino A, et al
    Safety and efficacy of a novel powered endoscopic debridement tissue resection device for management of difficult colon and foregut lesions: first multicenter U.S. experience.
    Gastrointest Endosc. 2021;93:640-646.
    PubMed     Abstract available


    February 2021
  25. DESAI M, Hamade N, Sharma P
    Screening for Barrett's esophagus: challenges in identifying the population at risk.
    Gastrointest Endosc. 2021;93:420-421.
    PubMed    


  26. CHEN Z, Ng H, Liu Y, Guo C, et al
    Endoscopic submucosal dissection of early squamous cell carcinoma of the soft palate.
    Gastrointest Endosc. 2021;93:517-518.
    PubMed    


    January 2021
  27. SUBRAMANIAN SK, Bhakta D, Thosani N
    Hepatocellular carcinoma masquerading as nodular Barrett's esophagus.
    Gastrointest Endosc. 2021 Jan 22. pii: S0016-5107(21)00038.
    PubMed    


  28. MOTOMURA D, Chung W, Bechara R
    Endoscopic therapy for T1b esophageal cancer.
    Gastrointest Endosc. 2021;93:282-283.
    PubMed    


  29. MWACHIRO MM, Dawsey SM
    The use of questionnaire-based risk-stratification tools in screening for esophageal squamous cell carcinoma.
    Gastrointest Endosc. 2021;93:119-121.
    PubMed    


  30. MOLENA D, DeMeester SR
    Response.
    Gastrointest Endosc. 2021;93:284-285.
    PubMed    


  31. OTAKI F, Iyer PG
    Response.
    Gastrointest Endosc. 2021;93:283-284.
    PubMed    


  32. STRUYVENBERG MR, de Groof AJ, van der Putten J, van der Sommen F, et al
    A computer-assisted algorithm for narrow-band imaging-based tissue characterization in Barrett's esophagus.
    Gastrointest Endosc. 2021;93:89-98.
    PubMed     Abstract available


    December 2020
  33. BANG CS, Lee JJ, Baik GH
    Computer-aided diagnosis of esophageal cancer and neoplasms in endoscopic images: a systematic review and meta-analysis of diagnostic test accuracy.
    Gastrointest Endosc. 2020 Dec 5. pii: S0016-5107(20)35023.
    PubMed     Abstract available


  34. JACOBS C, Draganov PV, Yang D
    Endoscopic submucosal dissection for esophageal neoplasia in the West: Are we there yet?
    Gastrointest Endosc. 2020;92:1275-1276.
    PubMed    


  35. SAKAGUCHI Y, Tsuji Y, Shinozaki T, Ohki D, et al
    Steroid injection and polyglycolic acid shielding to prevent stricture after esophageal endoscopic submucosal dissection: a retrospective comparative analysis (with video).
    Gastrointest Endosc. 2020;92:1176-1186.
    PubMed     Abstract available


    November 2020
  36. ISSA D, Patel M, Shah T
    Esophagectomy versus endoscopic resection for T1b esophageal adenocarcinoma: Depth matters!
    Gastrointest Endosc. 2020;92:1147-1148.
    PubMed    


  37. ETEMADI A, Dawsey SM, Abnet CC, Mwachiro MM, et al
    Predicting the risk of esophageal high-grade lesions in opportunistic screening.
    Gastrointest Endosc. 2020;92:1136-1137.
    PubMed    


    September 2020
  38. KRISHNAMOORTHI R
    Endoscopic therapy or surveillance for Barrett's esophagus with low-grade dysplasia: time to involve patients in shared decision making.
    Gastrointest Endosc. 2020;92:575-577.
    PubMed    


  39. VAN MUNSTER SN, Bergman JJGHM, Pouw RE
    Successful endoscopic treatment of Barrett's dysplasia is not just about the destination; it is about the journey.
    Gastrointest Endosc. 2020;92:551-553.
    PubMed    


  40. POUW RE, Klaver E, Phoa KN, van Vilsteren FG, et al
    Radiofrequency ablation for low-grade dysplasia in Barrett's esophagus: long-term outcome of a randomized trial.
    Gastrointest Endosc. 2020;92:569-574.
    PubMed     Abstract available


  41. LIPMAN G, Markar S, Gupta A, Haidry RJ, et al
    Learning curves and the influence of procedural volume for the treatment of dysplastic Barrett's esophagus.
    Gastrointest Endosc. 2020;92:543-550.
    PubMed     Abstract available


  42. JIN D, Wang J, Zhan Q, Huang K, et al
    The safety and efficacy of 2% vitamin C solution spray for relief of mucosal irritation caused by Lugol chromoendoscopy: a multicenter, randomized, double-blind, parallel trial.
    Gastrointest Endosc. 2020;92:554-564.
    PubMed     Abstract available


    August 2020
  43. AL-KAABI A, Schoon EJ, Deprez PH, Seewald S, et al
    Salvage endoscopic resection after definitive chemoradiotherapy for esophageal cancer: a Western experience.
    Gastrointest Endosc. 2020 Aug 4. pii: S0016-5107(20)34657.
    PubMed     Abstract available


  44. TAN S, Peng Y, Tang X
    Endoscopic surveillance of esophageal cancer before the treatment of achalasia.
    Gastrointest Endosc. 2020;92:457-458.
    PubMed    


    July 2020
  45. MOLENA D, DeMeester SR
    When less is just less: endoscopic therapy for submucosal T1b esophageal cancer.
    Gastrointest Endosc. 2020;92:40-43.
    PubMed    


  46. NIEUWENHUIS EA, Bergman JJ, Pouw RE
    What to do with our T1b esophageal adenocarcinoma patients?
    Gastrointest Endosc. 2020;92:226.
    PubMed    


  47. OTAKI F, Iyer PG
    Response.
    Gastrointest Endosc. 2020;92:226-227.
    PubMed    


  48. CHAN MQ, Balasubramanian G, Modi RM, Papachristou GI, et al
    Changing epidemiology of esophageal stent placement for dysphagia: a decade of trends and the impact of benign indications.
    Gastrointest Endosc. 2020;92:56-64.
    PubMed     Abstract available


  49. PITA I, Gigliano D, Afonso LP, Libanio D, et al
    Esophageal pseudoperforation during band mucosectomy of Barrett's esophagus: not all that glitters is gold (with video).
    Gastrointest Endosc. 2020;92:212-214.
    PubMed    


  50. OTAKI F, Ma GK, Krigel A, Dierkhising RA, et al
    Outcomes of patients with submucosal (T1b) esophageal adenocarcinoma: a multicenter cohort study.
    Gastrointest Endosc. 2020;92:31-39.
    PubMed     Abstract available


    June 2020
  51. FUKUDA H, Ishihara R, Kato Y, Matsunaga T, et al
    Comparison of performances of artificial intelligence versus expert endoscopists for real-time assisted diagnosis of esophageal squamous cell carcinoma (with video).
    Gastrointest Endosc. 2020 Jun 4. pii: S0016-5107(20)34378.
    PubMed     Abstract available


  52. CHEN W, Li H, Zheng R, Ren J, et al
    An initial screening strategy based on epidemiological information in esophageal cancer screening: a prospective evaluation in a community-based cancer screening cohort in rural China.
    Gastrointest Endosc. 2020 Jun 3. pii: S0016-5107(20)34402.
    PubMed     Abstract available


  53. DU C, Chai N, Linghu E, Tang X, et al
    Spraying vitamin C solution for relief of mucosal irritation caused by Lugol chromoendoscopy.
    Gastrointest Endosc. 2020;91:1409-1410.
    PubMed    


  54. PERBTANI Y, Qumseya BJ
    A prediction model for detection of esophageal squamous cell cancer: A new beginning or more of the same?
    Gastrointest Endosc. 2020;91:1261-1263.
    PubMed    


  55. HASHIMOTO R, Requa J, Dao T, Ninh A, et al
    Artificial intelligence using convolutional neural networks for real-time detection of early esophageal neoplasia in Barrett's esophagus (with video).
    Gastrointest Endosc. 2020;91:1264-1271.
    PubMed     Abstract available


  56. DE GROOF AJ, Struyvenberg MR, Fockens KN, van der Putten J, et al
    Deep learning algorithm detection of Barrett's neoplasia with high accuracy during live endoscopic procedures: a pilot study (with video).
    Gastrointest Endosc. 2020;91:1242-1250.
    PubMed     Abstract available


  57. LIU Z, Guo C, He Y, Chen Y, et al
    A clinical model predicting the risk of esophageal high-grade lesions in opportunistic screening: a multicenter real-world study in China.
    Gastrointest Endosc. 2020;91:1253-1260.
    PubMed     Abstract available


    May 2020
  58. DE GROOF AJ, Fockens KN, Struyvenberg MR, Pouw RE, et al
    Blue-light imaging and linked-color imaging improve visualization of Barrett's neoplasia by nonexpert endoscopists.
    Gastrointest Endosc. 2020;91:1050-1057.
    PubMed     Abstract available


    April 2020
  59. MCCARTY JC, Parker RK, Vidri RJ, Robinson KA, et al
    A retrospective cohort study of endoscopic therapy and esophagectomy for stage 1 esophageal cancer: less is more.
    Gastrointest Endosc. 2020 Apr 7. pii: S0016-5107(20)30034.
    PubMed     Abstract available


  60. ALSAYID M, Melson J
    Will magnet-assisted capsule endoscopy become a viable screening tool for Barrett's esophagus and esophageal varices?
    Gastrointest Endosc. 2020;91:782-784.
    PubMed    


  61. PECH O
    Lugol staining for early esophageal neoplasia: less is sometimes more.
    Gastrointest Endosc. 2020;91:771-772.
    PubMed    


  62. GENERE JR, Priyan H, Sawas T, Hanada Y, et al
    Safety and histologic outcomes of endoscopic submucosal dissection with a novel articulating knife for esophageal neoplasia.
    Gastrointest Endosc. 2020;91:797-805.
    PubMed     Abstract available


  63. LIU D, Yu XH, Zheng QF, Liu BR, et al
    A giant lumen-occluding hemangioma at the cervical esophagus resected by endoscopic submucosal dissection.
    Gastrointest Endosc. 2020;91:944-945.
    PubMed    


  64. GOTODA T, Kanzaki H, Okamoto Y, Obayashi Y, et al
    Tolerability and efficacy of the concentration of iodine solution during esophageal chromoendoscopy: a double-blind randomized controlled trial.
    Gastrointest Endosc. 2020;91:763-770.
    PubMed     Abstract available


    February 2020
  65. SUBRAMANIAM S, Kandiah K, Schoon E, Aepli P, et al
    Development and validation of the international Blue Light Imaging for Barrett's Neoplasia Classification.
    Gastrointest Endosc. 2020;91:310-320.
    PubMed     Abstract available


  66. OHMORI M, Ishihara R, Aoyama K, Nakagawa K, et al
    Endoscopic detection and differentiation of esophageal lesions using a deep neural network.
    Gastrointest Endosc. 2020;91:301-309.
    PubMed     Abstract available


  67. FRANCOIS S, Waldbillig C, Lasser L, Ngassa M, et al
    Giant fibrovascular polyp of the esophagus.
    Gastrointest Endosc. 2020;91:442-443.
    PubMed    


  68. KURIBAYASHI S, Matsumura N, Sohda M, Kuwano H, et al
    Risk of perforation during endoscopic resection of esophageal lesions in patients with systemic sclerosis.
    Gastrointest Endosc. 2020;91:441-442.
    PubMed    


  69. GUPTA N, Kumar T, Rao SA
    EUS-guided FNA from suspected bony metastasis in the vertebral body.
    Gastrointest Endosc. 2020;91:445-446.
    PubMed    


    January 2020
  70. THAKKAR SJ, Kochhar GS
    Artificial intelligence for real-time detection of early esophageal cancer: another set of eyes to better visualize.
    Gastrointest Endosc. 2020;91:52-54.
    PubMed    


  71. UPPAL DS, Wang AY
    Traction-assisted endoscopic submucosal dissection in the esophagus: Should we all be flossing?
    Gastrointest Endosc. 2020;91:66-69.
    PubMed    


  72. FREI NF, Stachler MD, Bergman JJGHM
    Risk stratification in Barrett's esophagus patients with diagnoses of indefinite for dysplasia: the definite silver bullet has not (yet) been found.
    Gastrointest Endosc. 2020;91:11-13.
    PubMed    


  73. KRISHNAMOORTHI R, Mohan BP, Jayaraj M, Wang KK, et al
    Risk of progression in Barrett's esophagus indefinite for dysplasia: a systematic review and meta-analysis.
    Gastrointest Endosc. 2020;91:3-10.
    PubMed     Abstract available


    December 2019
  74. MWACHIRO M
    Through-the-scope esophageal stents for malignant dysphagia: A double-edged sword?
    Gastrointest Endosc. 2019;90:980-982.
    PubMed    


    November 2019
  75. IYER PG
    Dysplasia detection in Barrett's esophagus: Is the glass half full or half empty?
    Gastrointest Endosc. 2019;90:742-744.
    PubMed    


  76. CHHABRA P, Bhasin DK
    Risk assessment for Barrett's esophagus: so near, yet so far!
    Gastrointest Endosc. 2019;90:718-720.
    PubMed    


    October 2019
  77. KHAN AT, Dhorajiya P, Lung E
    A rapidly regressive esophageal squamous papilloma.
    Gastrointest Endosc. 2019;90:684-685.
    PubMed    


    September 2019
  78. QUMSEYA B, Sultan S, Bain P, Jamil L, et al
    ASGE guideline on screening and surveillance of Barrett's esophagus.
    Gastrointest Endosc. 2019;90:335-359.
    PubMed    


  79. TRINDADE AJ, Navaneethan U, Aslanian HR, Bhutani MS, et al
    Advances in the diagnosis and surveillance of Barrett's esophagus (with videos).
    Gastrointest Endosc. 2019;90:325-334.
    PubMed     Abstract available


  80. OMAR M, Thaker AM, Wani S, Simon V, et al
    Anatomic location of Barrett's esophagus recurrence after endoscopic eradication therapy: development of a simplified surveillance biopsy strategy.
    Gastrointest Endosc. 2019;90:395-403.
    PubMed     Abstract available


  81. OVERWATER A, van der Meulen KE, Kunzli HT, Schoon EJ, et al
    Optimizing histopathologic evaluation of EMR specimens of Barrett's esophagus-related neoplasia: a randomized study of 3 specimen handling methods.
    Gastrointest Endosc. 2019;90:384-392.
    PubMed     Abstract available


    August 2019
  82. GUO L, Xiao X, Wu C, Zeng X, et al
    Real-time automated diagnosis of precancerous lesion and early esophageal squamous cell carcinoma using a deep learning model (with videos).
    Gastrointest Endosc. 2019 Aug 21. pii: S0016-5107(19)32187.
    PubMed     Abstract available


  83. YOSHIDA M, Takizawa K, Nonaka S, Shichijo S, et al
    Conventional versus traction-assisted endoscopic submucosal dissection for large esophageal cancers: a multicenter, randomized controlled trial (with video).
    Gastrointest Endosc. 2019 Aug 21. pii: S0016-5107(19)32183.
    PubMed     Abstract available


  84. WANG G, Liu BR, Hu Z
    Combined Endoscopic-Laparoscopic Radical Esophagectomy and Lymph Node Dissection for the Treatment of Esophageal Squamous Cell Carcinoma.
    Gastrointest Endosc. 2019 Aug 20. pii: S0016-5107(19)32142.
    PubMed    


  85. KE Y, van Munster SN, Xue L, He S, et al
    Prospective study of endoscopic focal cryoballoon ablation for esophageal squamous cell neoplasia in China.
    Gastrointest Endosc. 2019;90:204-212.
    PubMed     Abstract available


    July 2019
  86. CAI SL, Li B, Tan WM, Niu XJ, et al
    Using deep learning system in endoscopy for screening of early esophageal squamous cell carcinoma (with video).
    Gastrointest Endosc. 2019 Jul 11. pii: S0016-5107(19)32051.
    PubMed     Abstract available


  87. RAIJMAN I
    Antireflux esophageal stents: Do we have a winner?
    Gastrointest Endosc. 2019;90:75-76.
    PubMed    


  88. DUA KS, DeWitt JM, Kessler WR, Diehl DL, et al
    A phase III, multicenter, prospective, single-blinded, noninferiority, randomized controlled trial on the performance of a novel esophageal stent with an antireflux valve (with video).
    Gastrointest Endosc. 2019;90:64-74.
    PubMed     Abstract available


    June 2019
  89. VERMEULEN BD, Reijm AN, van der Bogt RD, van Hooft JE, et al
    Through-the-scope placement of a fully covered metal stent for palliation of malignant dysphagia: a prospective cohort study (with video).
    Gastrointest Endosc. 2019 Jun 29. pii: S0016-5107(19)32018.
    PubMed     Abstract available


  90. POUW RE
    Endoscopic resection of superficial esophageal adenocarcinoma: the Japanese point of view.
    Gastrointest Endosc. 2019;89:1129-1131.
    PubMed    


  91. IWAMURO M, Sakae H, Tanaka T, Okada H, et al
    White globe appearance in gastric high-grade dysplasia.
    Gastrointest Endosc. 2019;89:1254-1255.
    PubMed    


  92. ABE S, Ishihara R, Takahashi H, Ono H, et al
    Long-term outcomes of endoscopic resection and metachronous cancer after endoscopic resection for adenocarcinoma of the esophagogastric junction in Japan.
    Gastrointest Endosc. 2019;89:1120-1128.
    PubMed     Abstract available


    May 2019
  93. NAKAGAWA K, Ishihara R, Aoyama K, Ohmori M, et al
    Classification for invasion depth of esophageal squamous cell carcinoma using a deep neural network compared with experienced endoscopists.
    Gastrointest Endosc. 2019 May 8. pii: S0016-5107(19)31675.
    PubMed     Abstract available


  94. SHAHEEN NJ
    Where is the finish line for endoscopic eradication therapy in Barrett's esophagus?
    Gastrointest Endosc. 2019;89:926-928.
    PubMed    


  95. MEISELMAN M, Melitas C, Auran T
    Esophageal subepithelial nodule: bronchial artery aneurysm with fistulization to the pulmonary artery (with video).
    Gastrointest Endosc. 2019;89:1063-1064.
    PubMed    


  96. SAWAS T, Alsawas M, Bazerbachi F, Iyer PG, et al
    Persistent intestinal metaplasia after endoscopic eradication therapy of neoplastic Barrett's esophagus increases the risk of dysplasia recurrence: meta-analysis.
    Gastrointest Endosc. 2019;89:913-925.
    PubMed     Abstract available


    April 2019
  97. KAHN A, Crowell MD, Fleischer DE
    Reducing the risk of esophageal squamous cell carcinoma: out with the old; in with the new.
    Gastrointest Endosc. 2019;89:733-735.
    PubMed    


  98. LADABAUM U
    How I do it: Does this cost-effectiveness analysis convince me about screening for Barrett's esophagus?
    Gastrointest Endosc. 2019;89:723-725.
    PubMed    


  99. YU X, van Munster SN, Zhang Y, Xue L, et al
    Durability of radiofrequency ablation for treatment of esophageal squamous cell neoplasia: 5-year follow-up of a treated cohort in China.
    Gastrointest Endosc. 2019;89:736-748.
    PubMed     Abstract available


  100. PEERALLY MF, Bhandari P, Ragunath K, Barr H, et al
    Radiofrequency ablation compared with argon plasma coagulation after endoscopic resection of high-grade dysplasia or stage T1 adenocarcinoma in Barrett's esophagus: a randomized pilot study (BRIDE).
    Gastrointest Endosc. 2019;89:680-689.
    PubMed     Abstract available


  101. DE GROOF AJ, Swager AF, Pouw RE, Weusten BLAM, et al
    Blue-light imaging has an additional value to white-light endoscopy in visualization of early Barrett's neoplasia: an international multicenter cohort study.
    Gastrointest Endosc. 2019;89:749-758.
    PubMed     Abstract available


    February 2019
  102. YANG F, Ma D, Li Z
    Screening for esophageal squamous cell carcinoma: insight from experience with Barrett's esophagus.
    Gastrointest Endosc. 2019;89:443-444.
    PubMed    


  103. CODIPILLY DC, Qin Y, Dawsey SM, Kisiel J, et al
    Response.
    Gastrointest Endosc. 2019;89:444.
    PubMed    


  104. DESAI M, Lieberman DA, Kennedy KF, Hamade N, et al
    Increasing prevalence of high-grade dysplasia and adenocarcinoma on index endoscopy in Barrett's esophagus over the past 2 decades: data from a multicenter U.S. consortium.
    Gastrointest Endosc. 2019;89:257-263.
    PubMed     Abstract available


  105. JASWANI TS, Williams AJ, Grider DJ, Yeaton P, et al
    Primary esophageal choriocarcinoma: an unusual cause of myocardial infarction.
    Gastrointest Endosc. 2019;89:432-433.
    PubMed    


  106. EVERSON MA, Lovat LB, Graham DG, Bassett P, et al
    Virtual chromoendoscopy by using optical enhancement improves the detection of Barrett's esophagus-associated neoplasia.
    Gastrointest Endosc. 2019;89:247-256.
    PubMed     Abstract available


  107. IWAMURO M, Sakae H, Tanaka T, Okada H, et al
    Heterotopic bone formation in the esophagus.
    Gastrointest Endosc. 2019;89:429-430.
    PubMed    


    January 2019
  108. SMITH ZL, Dua KS
    Patient selection in studies evaluating esophageal stents during neoadjuvant therapy.
    Gastrointest Endosc. 2019;89:205-206.
    PubMed    


    December 2018
  109. ZHAI W, Zhao L, Fan Z
    Concerns about transplantation of autologous esophageal mucosa to prevent stricture after circumferential endoscopic submucosal dissection.
    Gastrointest Endosc. 2018;88:969.
    PubMed    


    November 2018
  110. JIANG K, Lauwers GY
    The dawn of a new era: performance measurement for the pathologic diagnosis of Barrett's esophagus-associated dysplasia.
    Gastrointest Endosc. 2018;88:816-817.
    PubMed    


  111. ORTIZ-FERNANDEZ-SORDO J, Ragunath K
    Barrett's ablation: blowing hot, blowing cold.
    Gastrointest Endosc. 2018;88:804-806.
    PubMed    


  112. DAVISON JM, Shah MB, Deitrick C, Chennat J, et al
    Low-grade dysplasia diagnosis ratio and progression metrics identify variable Barrett's esophagus risk stratification proficiency in independent pathology practices.
    Gastrointest Endosc. 2018;88:807-815.
    PubMed     Abstract available


  113. VAN MUNSTER SN, Overwater A, Haidry R, Bisschops R, et al
    Focal cryoballoon versus radiofrequency ablation of dysplastic Barrett's esophagus: impact on treatment response and postprocedural pain.
    Gastrointest Endosc. 2018;88:795-803.
    PubMed     Abstract available


    October 2018
  114. WANG QL, Lagergren J, Xie SH
    Prediction of individuals at high absolute risk of esophageal squamous cell carcinoma.
    Gastrointest Endosc. 2018 Oct 25. pii: S0016-5107(18)33198.
    PubMed     Abstract available


  115. NAKAJO K, Yoda Y, Hori K, Takashima K, et al
    Technical feasibility of endoscopic submucosal dissection for local failure after chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.
    Gastrointest Endosc. 2018;88:637-646.
    PubMed     Abstract available


  116. LIU L, Wei H, Fu J
    Autologous esophageal mucosa transplantation to prevent esophageal stricture after endoscopic submucosal dissection: promising, but too early to draw a conclusion.
    Gastrointest Endosc. 2018;88:784.
    PubMed    


  117. CHUA T, Fukami N
    Upfront endoscopic submucosal dissection for superficial squamous cell carcinoma is superior to upfront surgical therapy.
    Gastrointest Endosc. 2018;88:634-636.
    PubMed    


  118. POUW RE, Beyna T, Belghazi K, Koch AD, et al
    A prospective multicenter study using a new multiband mucosectomy device for endoscopic resection of early neoplasia in Barrett's esophagus.
    Gastrointest Endosc. 2018;88:647-654.
    PubMed     Abstract available


  119. WANG SH, Lin CK, Chang YC, Lee TH, et al
    An atypical infection of the esophagus mimicking malignancy.
    Gastrointest Endosc. 2018;88:765-766.
    PubMed    


    September 2018
  120. CANTO MI, Shaheen NJ, Almario JA, Voltaggio L, et al
    Multifocal nitrous oxide cryoballoon ablation with or without EMR for treatment of neoplastic Barrett's esophagus (with video).
    Gastrointest Endosc. 2018;88:438-446.
    PubMed     Abstract available


    August 2018
  121. HORIE Y, Yoshio T, Aoyama K, Yoshimizu S, et al
    The diagnostic outcomes of esophageal cancer by artificial intelligence using convolutional neural networks.
    Gastrointest Endosc. 2018 Aug 15. pii: S0016-5107(18)32926.
    PubMed     Abstract available


    July 2018
  122. DE LA MORA LEVY JG, Manzano-Robleda MDC
    Nutrition before chemoradiotherapy or surgery: Temporary esophageal stents or tube feeding? Is the evidence hard to swallow?
    Gastrointest Endosc. 2018;88:32-34.
    PubMed    


  123. GOLDBLUM JR, Shaheen NJ, Vennalaganti PR, Sharma P, et al
    WATS for Barrett's surveillance.
    Gastrointest Endosc. 2018;88:201-202.
    PubMed    


  124. GARMAN KS, McCall SJ
    Esophageal submucosal glands as a potential source of subsquamous intestinal metaplasia in Barrett's esophagus.
    Gastrointest Endosc. 2018;88:200-201.
    PubMed    


  125. ALSHELLEH M, Inamdar S, McKinley M, Stewart M, et al
    Incremental yield of dysplasia detection in Barrett's esophagus using volumetric laser endomicroscopy with and without laser marking compared with a standardized random biopsy protocol.
    Gastrointest Endosc. 2018;88:35-42.
    PubMed     Abstract available


  126. YU FJ, Shih HY, Wu CY, Chuang YS, et al
    Enteral nutrition and quality of life in patients undergoing chemoradiotherapy for esophageal carcinoma: a comparison of nasogastric tube, esophageal stent, and ostomy tube feeding.
    Gastrointest Endosc. 2018;88:21-31.
    PubMed     Abstract available


    June 2018
  127. BELGHAZI K, Pouw RE, Bergman JJ
    In the expanding arena of endoscopic management for Barrett's neoplasia, how should we fit in endoscopic submucosal dissection?
    Gastrointest Endosc. 2018;87:1394-1395.
    PubMed    


  128. SIU W, Murray GI, McKinlay A, Phull P, et al
    Extensive esophageal papillomatosis after chemoradiotherapy for squamous cell carcinoma.
    Gastrointest Endosc. 2018;87:1581-1582.
    PubMed    


  129. NAGPAL SJS, Yi JE, Wong Kee Song LM, Topazian MD, et al
    Mucinous adenocarcinoma of unknown primary presenting with dysphagia.
    Gastrointest Endosc. 2018;87:1582-1583.
    PubMed    


    May 2018
  130. KACHAAMY T, Prakash R, Kundranda M, Batish R, et al
    Liquid nitrogen spray cryotherapy for dysphagia palliation in patients with inoperable esophageal cancer.
    Gastrointest Endosc. 2018 May 8. pii: S0016-5107(18)32673.
    PubMed     Abstract available


  131. TAKEUCHI M, Suda K, Hamamoto Y, Kato M, et al
    Technical feasibility and oncological safety of diagnostic endoscopic resection for superficial esophageal cancer.
    Gastrointest Endosc. 2018 May 8. pii: S0016-5107(18)32672.
    PubMed     Abstract available


  132. MIN YW, Lee H, Song BG, Min BH, et al
    Comparison of endoscopic submucosal dissection and surgery for superficial esophageal squamous cell carcinoma: A propensity score-matched analysis.
    Gastrointest Endosc. 2018 May 8. pii: S0016-5107(18)32671.
    PubMed     Abstract available


  133. LI P, Li W, Gong S
    Endoscopic submucosal dissection for early Barrett's esophagus neoplasia.
    Gastrointest Endosc. 2018;87:1368.
    PubMed    


  134. SHARMA P, Allen JE, Gorrepati VS, Gupta N, et al
    Improving quality of care in patients with Barrett's esophagus by measuring and improving neoplasia detection rates.
    Gastrointest Endosc. 2018;87:1195-1197.
    PubMed    


    April 2018
  135. CODIPILLY DC, Qin Y, Dawsey SM, Kisiel J, et al
    Screening for esophageal squamous cell carcinoma: recent advances.
    Gastrointest Endosc. 2018 Apr 27. pii: S0016-5107(18)32662.
    PubMed    


  136. LIAO Z, Liao G, Yang X, Peng X, et al
    Transplantation of autologous esophageal mucosa to prevent stricture after circumferential endoscopic submucosal dissection of early esophageal cancer (with video).
    Gastrointest Endosc. 2018 Apr 25. pii: S0016-5107(18)32659.
    PubMed     Abstract available


  137. DI L, Fu KI, Liu X, Zhu R, et al
    Superficial esophageal squamous cell carcinoma resembling epidermoid metaplasia of the esophagus.
    Gastrointest Endosc. 2018 Apr 5. pii: S0016-5107(18)30263.
    PubMed    


  138. BALDAQUE-SILVA F, Omae M
    Endoscopic submucosal dissection learning curve and role in the treatment of Barrett's neoplasia.
    Gastrointest Endosc. 2018;87:1162.
    PubMed    


  139. WANI S, Qumseya B, Sultan S, Agrawal D, et al
    Endoscopic eradication therapy for patients with Barrett's esophagus-associated dysplasia and intramucosal cancer.
    Gastrointest Endosc. 2018;87:907-931.
    PubMed    


  140. VAN DER VEEN A, Bogte A, Petri BJ, Ruurda JP, et al
    Massive esophageal hemorrhage.
    Gastrointest Endosc. 2018;87:1152-1153.
    PubMed    


  141. YAMAKAWA K, Kurita A, Azuma S, Kudo Y, et al
    Metastatic melanoma in the ampulla of Vater.
    Gastrointest Endosc. 2018;87:1156-1158.
    PubMed    


    February 2018
  142. KOHLI DR, Faigel DO
    Esophageal leiomyomas: Making mole hills out of mole hills?
    Gastrointest Endosc. 2018;87:378-379.
    PubMed    


  143. RIBEIRO MSI, da Costa Martins B, Simas de Lima M, Franco MC, et al
    Self-expandable metal stent for malignant esophagorespiratory fistula: predictive factors associated with clinical failure.
    Gastrointest Endosc. 2018;87:390-396.
    PubMed     Abstract available


  144. ABDELFATAH MM, Grimm IS, Gangarosa LM, Baron TH, et al
    Cohort study comparing the diagnostic yields of 2 different EUS fine-needle biopsy needles.
    Gastrointest Endosc. 2018;87:495-500.
    PubMed     Abstract available


  145. SHIBAGAKI K, Ishimura N, Oshima N, Mishiro T, et al
    Esophageal triamcinolone acetonide-filling method: a novel procedure to prevent stenosis after extensive esophageal endoscopic submucosal dissection (with videos).
    Gastrointest Endosc. 2018;87:380-389.
    PubMed     Abstract available


  146. SOLOMON SS, Kohli DR, Smallfield GB
    Esophageal cryoablation using retrograde per-gastrostomy ventilation in a patient with pharyngoesophageal stenosis.
    Gastrointest Endosc. 2018;87:607-608.
    PubMed    


  147. CODIPILLY DC, Fang H, Alexander JA, Katzka DA, et al
    Subepithelial esophageal tumors: a single-center review of resected and surveilled lesions.
    Gastrointest Endosc. 2018;87:370-377.
    PubMed     Abstract available


  148. VENNALAGANTI PR, Kaul V, Wang KK, Falk GW, et al
    Increased detection of Barrett's esophagus-associated neoplasia using wide-area trans-epithelial sampling: a multicenter, prospective, randomized trial.
    Gastrointest Endosc. 2018;87:348-355.
    PubMed     Abstract available


  149. CANTO MI, Abrams JA, Kunzli HT, Weusten B, et al
    Nitrous oxide cryotherapy for treatment of esophageal squamous cell neoplasia: initial multicenter international experience with a novel portable cryoballoon ablation system (with video).
    Gastrointest Endosc. 2018;87:574-581.
    PubMed     Abstract available


    January 2018
  150. BELGHAZI K, van Vilsteren FGI, Weusten BLAM, Meijer SL, et al
    Long-term follow-up results of stepwise radical endoscopic resection for Barrett's esophagus with early neoplasia.
    Gastrointest Endosc. 2018;87:77-84.
    PubMed     Abstract available


  151. MORIARTY JP, Shah ND, Rubenstein JH, Blevins CH, et al
    Costs associated with Barrett's esophagus screening in the community: an economic analysis of a prospective randomized controlled trial of sedated versus hospital unsedated versus mobile community unsedated endoscopy.
    Gastrointest Endosc. 2018;87:88-94.
    PubMed     Abstract available


  152. TOYONAGA H, Fukushima M, Inokuma T, Imai Y, et al
    Mantle cell lymphoma involving the esophagus evaluated by magnifying endoscopy with narrow-band imaging.
    Gastrointest Endosc. 2018;87:305-306.
    PubMed    


    November 2017
  153. DU C, Linghu E
    Treatment of esophageal submucosal tumors: endoscopic submucosal tunneling dissection versus thoracoscopic enucleation.
    Gastrointest Endosc. 2017;86:925.
    PubMed    


  154. BERTANI H, Frazzoni M, Conigliaro R
    Are we ready to move toward digital image interpretation in Barrett's esophagus surveillance?
    Gastrointest Endosc. 2017;86:847-848.
    PubMed    


    October 2017
  155. DAS KK, Falk GW
    Long-term outcomes for cryotherapy in Barrett's esophagus with high-grade dysplasia: just cracking the ice.
    Gastrointest Endosc. 2017;86:633-635.
    PubMed    


  156. IYER PG
    Endoscopic submucosal dissection in endotherapy for Barrett's esophagus-related dysplasia and neoplasia: An essential or optional technique?
    Gastrointest Endosc. 2017;86:623-625.
    PubMed    


  157. SIDDIKI H, Fukami N
    Endoscopic submucosal dissection for Barrett's neoplasia: decade of experience, little progress. Is ESD thE-BEST for complex Barrett's neoplasia?
    Gastrointest Endosc. 2017;86:619-622.
    PubMed    


    September 2017
  158. SAFIRI S, Ayubi E
    Efficacy and safety of endoscopic submucosal tunnel dissection for superficial esophageal squamous cell carcinoma: a propensity score matching analysis: methodologic issues.
    Gastrointest Endosc. 2017;86:575-576.
    PubMed    


  159. RODRIGUES-PINTO E, Pereira P, Baron TH, Macedo G, et al
    Should performance status impact stent decision-making in patients with long-term survival from advanced esophageal cancer?
    Gastrointest Endosc. 2017;86:572.
    PubMed    


    July 2017
  160. NAIK AD, El-Serag HB
    Endoscopic ablation of low-grade dysplasia in Barrett's esophagus: Have all the boxes been checked for us to move on?
    Gastrointest Endosc. 2017;86:130-132.
    PubMed    


    May 2017
  161. MITSUNAGA Y, Nishizawa T, Fujimoto A, Sasaki A, et al
    Successful endoscopic submucosal dissection for superficial esophageal cancer on solitary esophageal varix.
    Gastrointest Endosc. 2017 May 30. pii: S0016-5107(17)31984.
    PubMed    


  162. SWAGER AF, Tearney GJ, Leggett CL, van Oijen MGH, et al
    Identification of volumetric laser endomicroscopy features predictive for early neoplasia in Barrett's esophagus using high-quality histological correlation.
    Gastrointest Endosc. 2017;85:918-926.
    PubMed     Abstract available


    April 2017
  163. WAGH MS, Draganov PV
    Per-oral endoscopic tunneling for restoration of the esophagus: a novel endoscopic submucosal dissection technique for therapy of complete esophageal obstruction.
    Gastrointest Endosc. 2017;85:722-727.
    PubMed     Abstract available


  164. QIN Y, Halland M
    Esophageal self-dilations as a treatment for refractory benign esophageal strictures.
    Gastrointest Endosc. 2017;85:869.
    PubMed    


    March 2017
  165. DESAI M, Saligram S, Gupta N, Vennalaganti P, et al
    Efficacy and safety outcomes of multimodal endoscopic eradication therapy in Barrett's esophagus-related neoplasia: a systematic review and pooled analysis.
    Gastrointest Endosc. 2017;85:482-495.
    PubMed     Abstract available


    February 2017
  166. SAMARASENA J, Chen CL, Chin M, Chang K, et al
    Successful closure of a cryotherapy-induced bleeding jejunal perforation with the over-the-scope clip system.
    Gastrointest Endosc. 2017;85:451.
    PubMed    


  167. KOUNTOURAS J, Polyzos SA, Zeglinas C, Tzathas C, et al
    Helicobacter pylori-related metabolic syndrome as predictor of progression to esophageal carcinoma in a subpopulation-based Barrett's esophagus cohort.
    Gastrointest Endosc. 2017;85:462-463.
    PubMed    


  168. CHEN WC, Wolfsen H
    Role of radiofrequency ablation in esophageal squamous dysplasia and early neoplasia.
    Gastrointest Endosc. 2017;85:330-331.
    PubMed    


    January 2017
  169. AKASAKA T, Takeuchi Y, Uedo N, Ishihara R, et al
    "Underwater" endoscopic submucosal dissection for superficial esophageal neoplasms.
    Gastrointest Endosc. 2017;85:251-252.
    PubMed    


  170. TRINDADE AJ, Passi M, Stein PH, Sejpal DV, et al
    Liquid nitrogen cryospray ablation in palliation of Barrett's esophagus-associated adenocarcinoma.
    Gastrointest Endosc. 2017;85:250-251.
    PubMed    


    June 2016
  171. WANG WL, Chang IW, Chen CC, Chang CY, et al
    A case series on the use of circumferential radiofrequency ablation for early esophageal squamous neoplasias in patients with esophageal varices.
    Gastrointest Endosc. 2016 Jun 27. pii: S0016-5107(16)30329.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: